Drupal-Bibcite0<style face="normal" font="default" size="100%">A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance with Oxpentifylline (HERO) trial</style>